Anzemet (Dolasetron Injection) and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Anzemet (Dolasetron Injection) and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dolasetron
Brand name: Anzemet
Synonyms: Anzemet
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Anzemet (Dolasetron Injection)-Insulin degludec
- Anzemet (Dolasetron Injection)-Insulin Degludec (U-100) Prefilled Pens
- Anzemet (Dolasetron Injection)-Insulin Degludec (U-100) Vials
- Anzemet (Dolasetron Injection)-Insulin Degludec (U-200) Prefilled Pens
- Anzemet (Dolasetron Injection)-Insulin degludec and liraglutide
- Anzemet (Dolasetron Injection)-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Anzemet (Dolasetron Tablets)
- Insulin aspart, recombinant Subcutaneous-Anzemet Injection
- Insulin aspart, recombinant Subcutaneous-Anzemet Oral
- Insulin aspart, recombinant Subcutaneous-AP-Hist DM
- Insulin aspart, recombinant Subcutaneous-Apadaz
- Insulin aspart, recombinant Subcutaneous-Apalutamide